A Case of Radiation Recall Dermatitis after Hormonal Therapy of Letrozol (Femara(R)) / 대한피부과학회지
Korean Journal of Dermatology
;
: 83-85, 2006.
Article
in Korean
| WPRIM
| ID: wpr-67928
ABSTRACT
Radiation recall dermatitis gap (RRD) is the development of an inflammatory reaction throughout a previously irradiated area, precipitated by the administration of certain drugs. Usually chemotherapeutic agents have been associated with RRD, but other drugs reported include tamoxifen, interferon alfa-2b, simvastatin, and antituberculous drugs. We present a case of RRD after chemotherapy with letrozol (Femara(R)). Letrozol is a third generation aromatase inhibitor, which acts as an anti-estrogen agent. This is the first reported case of RRD triggered by letrozol.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Radiodermatitis
/
Tamoxifen
/
Aromatase
/
Interferons
/
Simvastatin
/
Drug Therapy
Language:
Korean
Journal:
Korean Journal of Dermatology
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS